ICH E6 (R3) Guideline on good clinical practice (GCP)

International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use

GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5

23 January 2025. Date for coming into effect 23 July 2025

ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.​

The overarching principles and Annex 1, adopted by ICH and CHMP, came into effect on 23 July 2025.

With the public consultation now concluded, the Annex 2 is expected to be finalised later in 2025.

 

TABLE OF CONTENTS

I. INTRODUCTION 
II. PRINCIPLES OF ICH GCP
III.  ANNEX 1
1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC) 
2.  INVESTIGATOR 
3. SPONSOR 
4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR
Appendix A. INVESTIGATOR’S BROCHURE
Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL
GLOSSARY

 

© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.

Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000

Clinical Research News

Studie van de Radiological Society of North America: Geniculaire arterie-embolisatie vermindert pijn bij knieartrose gedurende 12 maanden
GLP-1 en vruchtbaarheid: Waarom afslankmedicijnen worden besproken in de voortplantingsgeneeskunde
Hoog Lp(a): Nieuwe studie test medicijncombinatie tegen erfelijk hartrisico
Afslankmedicijnen in verband gebracht met lager risico op bepaalde kankersoorten: Wat de nieuwe gegevens laten zien
Na een beroerte en hersenbloeding: Nieuwe studie test wanneer bloedverdunners nodig zijn
Eerste door AI ontworpen vaccin voltooit proeven op mensen
Bloed in de urine en vermoeden van een tumor: Nieuwe urinetest wordt vergeleken met cystoscopie en biopsie

Aankomende klinische onderzoeken

Clinical Research Jobs

More jobs

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

Abonneren